Yu HN - Search Results

1

Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC.

Kim DM, Kim MJ, Moon JH, Lee EY, Hong JK, Lee S, Koh DI, Ryu YS, Kim SM, Jung SA, Shin JS, Kim J, Park YS, Hong SW, Lee SH, Jung J, Park SS, Kim DY, Kim EH, Jeong HR, Gong JH, Kim J, Chan Kim S, Yu HN, Ki SY, Kim TW, Jin DH. Kim DM, et al. Among authors: yu hn. Biochem Biophys Res Commun. 2020 Jun 18;527(1):305-310. doi: 10.1016/j.bbrc.2020.04.095. Epub 2020 May 11. Biochem Biophys Res Commun. 2020. PMID: 32446385

2

CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.

Hong JK, Kim DY, Shin JS, Ryu YS, Moon JH, Koh DI, Lee S, Lee J, Lee WJ, Lee EY, Jung SA, Kim SC, Yu HN, Kim MJ, Hong SW, Park SS, Jung J, Kim SM, Kim EH, Jeong HR, Gong JH, Kim J, Kim TW, Jin DH. Hong JK, et al. Among authors: yu hn. Anticancer Res. 2022 Apr;42(4):1813-1819. doi: 10.21873/anticanres.15657. Anticancer Res. 2022. PMID: 35346999

3

Synthesis and biological evaluation of quinoxaline derivatives as specific c-Met kinase inhibitors.

Kim SC, Boggu PR, Yu HN, Ki SY, Jung JM, Kim YS, Park GM, Ma SH, Kim IS, Jung YH. Kim SC, et al. Among authors: yu hn. Bioorg Med Chem Lett. 2020 Jul 1;30(13):127189. doi: 10.1016/j.bmcl.2020.127189. Epub 2020 Apr 16. Bioorg Med Chem Lett. 2020. PMID: 32371098

4

1,4-dihydropyrazolo[4,3-d]imidazole phenyl derivatives: a novel type II Raf kinase inhibitors.

Yu H, Jung Y, Kim H, Lee J, Oh CH, Yoo KH, Sim T, Hah JM. Yu H, et al. Bioorg Med Chem Lett. 2010 Jun 15;20(12):3805-8. doi: 10.1016/j.bmcl.2010.04.039. Epub 2010 Apr 18. Bioorg Med Chem Lett. 2010. PMID: 20466542

5

Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell lines.

Lee J, Kim H, Yu H, Chung JY, Oh CH, Yoo KH, Sim T, Hah JM. Lee J, et al. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1573-7. doi: 10.1016/j.bmcl.2010.01.064. Epub 2010 Jan 21. Bioorg Med Chem Lett. 2010. PMID: 20149658

6

Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT.

Lee J, Ku T, Yu H, Chong K, Ryu SW, Choi K, Choi C. Lee J, et al. Cancer Lett. 2012 May 28;318(2):221-5. doi: 10.1016/j.canlet.2011.12.014. Epub 2011 Dec 17. Cancer Lett. 2012. PMID: 22182449

7

Differential dependency of human cancer cells on vascular endothelial growth factor-mediated autocrine growth and survival.

Lee J, Lee J, Yu H, Choi K, Choi C. Lee J, et al. Cancer Lett. 2011 Oct 28;309(2):145-50. doi: 10.1016/j.canlet.2011.05.026. Epub 2011 Jun 16. Cancer Lett. 2011. PMID: 21683519

8

Structure based design and syntheses of amino-1H-pyrazole amide derivatives as selective Raf kinase inhibitors in melanoma cells.

Kim MH, Kim M, Yu H, Kim H, Yoo KH, Sim T, Hah JM. Kim MH, et al. Bioorg Med Chem. 2011 Mar 15;19(6):1915-23. doi: 10.1016/j.bmc.2011.01.067. Epub 2011 Feb 3. Bioorg Med Chem. 2011. PMID: 21353571

9

Constitutive Expression of MAP Kinase Phosphatase-1 Confers Multi-drug Resistance in Human Glioblastoma Cells.

Yu H, Park J, Lee J, Choi K, Choi C. Yu H, et al. Cancer Res Treat. 2012 Sep;44(3):195-201. doi: 10.4143/crt.2012.44.3.195. Epub 2012 Sep 30. Cancer Res Treat. 2012. PMID: 23091446 Free PMC article.

10

Syntheses of phenylpyrazolodiazepin-7-ones as conformationally rigid analogs of aminopyrazole amide scaffold and their antiproliferative effects on cancer cells.

Kim H, Kim M, Lee J, Yu H, Hah JM. Kim H, et al. Bioorg Med Chem. 2011 Nov 15;19(22):6760-7. doi: 10.1016/j.bmc.2011.09.042. Epub 2011 Oct 1. Bioorg Med Chem. 2011. PMID: 22014755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page